Methylnaltrexone (Relistor) is a peripherally-acting μ-opioid antagonist used for the treatment of opioid induced constipation.
Two independent organizations have recently published updated clinical information on this drug:
The Scottish Medicines Consortium also reviewed Relistor in January 2009.